Clare Appleby

Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial

Adeel Shahzad, Ian Kemp, Christine Mars et al. · The Lancet · 2014 · 536 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

Javier Escaned, Carlos Collet, Nicola Ryan et al. · European Heart Journal · 2017 · 295 citations · Full text

Medicine, Cardiology, Surgery +17

Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction

Peter McCartney, Hany Eteiba, Annette Maznyczka et al. · JAMA · 2019 · 142 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with <i>de novo</i> three-vessel disease: final results of the SYNTAX II study

Adrian Banning, Patrick W. Serruys, Giovanni Luigi De Maria et al. · European Heart Journal · 2021 · 106 citations · Full text

Medicine, Cardiology, Surgery +13

Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial

Taku Asano, Yuki Katagiri, Chun Chin Chang et al. · JACC: Cardiovascular Interventions · 2019 · 76 citations

Medicine, Cardiology, Surgery +14